Filing Details

Accession Number:
0001140361-13-019035
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-05-06 20:05:11
Reporting Period:
2013-04-30
Filing Date:
2013-05-06
Accepted Time:
2013-05-06 20:05:11
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1048477 Biomarin Pharmaceutical Inc BMRN Pharmaceutical Preparations (2834) 680397820
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1514980 Brian Mueller 105 Digital Drive
Novato CA 94949
Vp, Corporate Controller No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-04-30 581 $23.21 13,860 No 5 A Direct
Common Stock Acquisiton 2013-05-02 4,874 $14.39 18,734 No 4 M Direct
Common Stock Disposition 2013-05-02 4,874 $65.35 13,860 No 4 S Direct
Common Stock Disposition 2013-05-02 4,457 $65.48 9,403 No 4 S Direct
Common Stock Acquisiton 2013-05-03 7,500 $21.51 16,903 No 4 M Direct
Common Stock Disposition 2013-05-03 7,500 $67.11 9,403 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 5 A Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Common Stock Disposition 2013-05-02 7,500 $0.00 7,500 $21.51
Common Stock Stock Option (right to buy) Common Stock Disposition 2013-05-03 4,874 $0.00 4,874 $14.39
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
15,200 2010-11-12 2020-05-11 No 4 M Direct
521 2009-11-12 2019-05-11 No 4 M Direct
Footnotes
  1. The reporting person is reporting the acquisition of shares of the issuer's Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of November 1, 2012 to April 30, 2013.
  2. The price in column 4 is a weighted average price. The price actually received ranged from $65.385 to $65.344. The reportng person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  3. The price in column 4 is a weighted average price. The price actually received ranged from $65.481 to $65.472. The reportng person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  4. The price in column 4 is a weighted average price. The price actually received ranged from $67.105 to $67.16. The reportng person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  5. Original option grant vests 6/48th on November 12, 2009 and 1/48th each on the 12th of each month thereafter.
  6. Original option grant vests 6/48th on November 12, 2010 and 1/48th each on the 12th of each month thereafter.
  7. Reflects the number of stock options that remain outstanding from this specific stock option grant following the reported transaction.